Gene · 53369
Papers1,954
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
521 to 540 of 1,954
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Effects of aerobic training on serum paraoxonase activity and its relationship with PON1-192 phenotypes in women. | J Sport Health Sci | 2016 | 30356554 | PubTator, text mining | PubMed |
| High-density lipoprotein cholesterol (HDL-C) in cardiovascular disease: effect of exercise training. | Integr Med Res | 2016 | 28462120 | PubTator, text mining | PubMed |
| Baicalin promotes cholesterol efflux by regulating the expression of SR-BI in macrophages. | Exp Ther Med | 2016 | 28105139 | PubTator, text mining | PubMed |
| Interferon Control of the Sterol Metabolic Network: Bidirectional Molecular Circuitry-Mediating Host Protection. | Front Immunol | 2016 | 28066443 | PubTator, text mining | PubMed |
| Altered lipoproteins in patients with systemic lupus erythematosus are associated with augmented oxidative stress: a potential role in atherosclerosis. | Arthritis Res Ther | 2016 | 28038677 | PubTator, text mining | PubMed |
| Modified Lipids and Lipoproteins in Chronic Kidney Disease: A New Class of Uremic Toxins. | Toxins (Basel) | 2016 | 27999257 | PubTator, text mining | PubMed |
| Network analysis of human post-mortem microarrays reveals novel genes, microRNAs, and mechanistic scenarios of potential importance in fighting huntington's disease. | Comput Struct Biotechnol J | 2016 | 27924190 | PubTator, text mining | PubMed |
| Refined purification strategy for reliable proteomic profiling of HDL2/3: Impact on proteomic complexity. | Sci Rep | 2016 | 27917957 | PubTator, text mining | PubMed |
| An unusual cause of anemia in cirrhosis: spur cell anemia, a case report with review of literature. | Gastroenterol Hepatol Bed Bench | 2016 | 27895861 | PubTator, text mining | PubMed |
| Nutrition, insulin resistance and dysfunctional adipose tissue determine the different components of metabolic syndrome. | World J Diabetes | 2016 | 27895819 | PubTator, text mining | PubMed |
| oxLDL and eLDL Induced Membrane Microdomains in Human Macrophages. | PLoS One | 2016 | 27870891 | PubTator, text mining | PubMed |
| Association of High-Density Lipoprotein Subclasses with Chronic Kidney Disease Progression, Atherosclerosis, and Klotho. | PLoS One | 2016 | 27861640 | PubTator, text mining | PubMed |
| Role of MicroRNA in Endothelial Dysfunction and Hypertension. | Curr Hypertens Rep | 2016 | 27837398 | PubTator, text mining | PubMed |
| SR-BI: Linking Cholesterol and Lipoprotein Metabolism with Breast and Prostate Cancer. | Front Pharmacol | 2016 | 27774064 | PubTator, text mining | PubMed |
| Impact of selective LDL apheresis on serum chemerin levels in patients with hypercholesterolemia. | Lipids Health Dis | 2016 | 27756331 | PubTator, text mining | PubMed |
| F2-Isoprostanes in HDL are bound to neutral lipids and phospholipids. | Free Radic Res | 2016 | 27750456 | PubTator, text mining | PubMed |
| Patients with Rheumatoid Arthritis Show Altered Lipoprotein Profiles with Dysfunctional High-Density Lipoproteins that Can Exacerbate Inflammatory and Atherogenic Process. | PLoS One | 2016 | 27736980 | PubTator, text mining | PubMed |
| Body mass index and glycemic control influence lipoproteins in children with type 1 diabetes. | J Clin Lipidol | 2016 | 27678442 | PubTator, text mining | PubMed |
| Comparing fluorescence-based cell-free assays for the assessment of antioxidative capacity of high-density lipoproteins. | Lipids Health Dis | 2016 | 27658709 | PubTator, text mining | PubMed |
| Statin action enriches HDL3 in polyunsaturated phospholipids and plasmalogens and reduces LDL-derived phospholipid hydroperoxides in atherogenic mixed dyslipidemia. | J Lipid Res | 2016 | 27581680 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/53369/papers?page=27